Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 292

Mail.ru collects Zakazaka for $18m

Mail.ru has acquired the remaining 90% stake in food delivery platform and portfolio company Zakazaka in a deal that valued the startup at $20m.

May 11, 2017

River Vision flows into Horizon in $145m deal

Horizon Pharma has agreed to pay $145m upfront to buy River Vision Development Corp, enabling GlaxoSmithKline and Lundbeck to exit.

May 10, 2017

Corporate investment bears fruits in Persimmon acquisition

Intel, ABB and Nidec Sankyo have exited Persimmon Technologies in an acquisition by Sumitomo Heavy Industries valued at almost $32m.

May 9, 2017

Shotspotter targets public markets

The Motorola Solutions-backed gunshot detection software provider plans to raise up to $34.5m in an initial public offering on Nasdaq.

May 9, 2017

Affinitas finds a Spark with merger deal

Affinitas is set to merge with fellow online dating company Spark Networks in a deal that will provide an exit to Rocket Internet and Medienguppe Pressedruck.

May 8, 2017

Ovid invades public markets with $75m IPO

The neurological disorder drug developer has floated in an initial public offering that gave pharmaceutical companies Sanofi and Takeda exits.

May 8, 2017

Intel exits as Quotient eats Crisp

The transaction, worth up to $57.5m, will allow Intel Capital and the Singapore state-owned EDBI to exit adtech provider Crisp Media.

May 5, 2017

Whirlpool swallows up recipe platform Yummly

Intel, Unilever and Bauer Media will exit online recipe recommendation platform Yummly, which was valued at $100m as of 2015, in an acquisition by appliance maker Whirlpool.

May 4, 2017

Yik Yak's founders give up the ghost

The Renren-backed social media platform has formally announced it will shut down this week, with Square paying about $1m for some of its engineers and IP.

May 4, 2017

Zymeworks zooms to public markets

The cancer-focused antibody developer has secured $58.5m in a US flotation that involved existing investors Celgene and Eli Lilly buying more than $7m of shares.

May 3, 2017

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here